These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3566234)

  • 1. Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients.
    Fainstein V; Bodey GP; Elting L; Maksymiuk A; Keating M; McCredie KB
    Antimicrob Agents Chemother; 1987 Jan; 31(1):11-5. PubMed ID: 3566234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
    Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
    Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
    Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
    Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
    Grasela TH; Goodwin SD; Pasko MT; Walawander CA; Raebel MA
    Ann Pharmacother; 1994 Feb; 28(2):252-60. PubMed ID: 8173147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
    Donnelly JP; Starke ID; Galton DA; Catovsky D; Goldman JM; Darrell JH
    J Hosp Infect; 1984 Mar; 5(1):83-91. PubMed ID: 6202753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mycoses in cancer patients.
    Meunier-Carpentier F
    Am J Med; 1983 Jan; 74(1B):74-9. PubMed ID: 6295156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
    Malik IA; Moid I; Aziz Z; Khan S; Suleman M
    Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for fungal infections in leukemia.
    Segal RE; Minamoto GY
    Curr Oncol Rep; 2001 May; 3(3):201-8. PubMed ID: 11296129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and treatment of fungal infections in neutropenic patients.
    von Paleske A; Müllerleile U; Gressler V; Garbrecht M; Hossfeld DK
    Haematol Blood Transfus; 1987; 30():545-6. PubMed ID: 3476385
    [No Abstract]   [Full Text] [Related]  

  • 12. Voriconazole versus amphotericin B in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K;
    Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
    Flynn TN; Kelsey SM; Hazel DL; Guest JF
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):543-50. PubMed ID: 10662479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    J Infect; 1991 Jan; 22(1):45-52. PubMed ID: 1848268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
    Johansen HK; Gøtzsche PC
    Cochrane Database Syst Rev; 2002; (2):CD000239. PubMed ID: 12076388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
    Johansen HK; Gotzsche PC
    Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
    Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies.
    Schulenburg A; Sperr W; Rabitsch W; Knöbl P; Thalhammer F
    Leuk Lymphoma; 2005 Aug; 46(8):1163-7. PubMed ID: 16085557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.